FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Sun Pharmaceutical Industries Cequa Recall

Cequa (cyclosporine ophthalmic solution) 0

SUN PHARMACEUTICAL INDUSTRIES INC · Princeton, NJ

Risk level
Class III
Reported by FDA
May 26, 2021
Recall ID
D-0391-2021
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Cequa starting May 7, 2021. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0391-2021 on May 26, 2021. Reason: Subpotent and Presence of Particulates . Status: Terminated.

Why it was recalled

Subpotent and Presence of Particulates .

Product description

Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 NDC 47335-506-96

Lot numbers, UPCs & expiration codes

Lot # 10009, exp. date 03/2022 10006, exp. date 01/2022

Where it was sold

Nationwide in the US

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0391-2021
Classification
Class III
Status
Terminated
Recall initiated
May 7, 2021
FDA report date
May 26, 2021
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC

Original FDA data

Every field from FDA enforcement report D-0391-2021, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
87922
Address
2 Independence Way
Code information
Lot # 10009, exp. date 03/2022 10006, exp. date 01/2022
Postal code
08540-6620
Report date
May 26, 2021
Product type
Drugs
Recall number
D-0391-2021
Classification
Class III
Recalling firm
SUN PHARMACEUTICAL INDUSTRIES INC
Termination date
Jun 17, 2022
Reason for recall
Subpotent and Presence of Particulates .
Voluntary / mandated
Voluntary: Firm initiated
Product description
Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 NDC 47335-506-96
Distribution pattern
Nationwide in the US
Recall initiation date
May 7, 2021
Initial firm notification
Letter
Center classification date
May 20, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0391-2021, published May 26, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls